₹550.70
−0.02%NSE close, 16 Nov 2026
+9.32%
Dr. Agarwal's Health Care is a small cap company, listed on NSE under the symbol AGARWALEYE. At ₹550.70 a share, the market values the whole company at ₹17,459 crore.
In FY26, it reported sales of ₹2,080 crore and a net profit of ₹133 crore, an operating margin of 27.4%.
The market values the company at 100.7 times its profit over the last twelve months and 7.80 times its book value; its return on equity is 7.8% and its borrowings are 0.09 times its equity.
Promoters hold 32.33% of the shares. Foreign institutions hold 49.56%, and domestic institutions, mutual funds among them, 15.87%.
Over the past year the share price has risen 9.3%, and it is 3.7% below its 52-week high.
₹ crore. Consolidated figures.
Execution of Media Agreement by the Company with GoodEdge Advisory Private Limited
Transcript of the Discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter and half year ended September 30, 2026, at the analyst call held on November 05, 2026, is attached.
Link of Recording
Monitoring Agency Report for the quarter ended September 30, 2026, is attached.
Corrigendum to the Outcome of Board Meeting held on November 05, 2026, is submitted
| Sales | 431 | 460 | 487 | 499 | 530 | 564 | 614 | 655 |
|---|---|---|---|---|---|---|---|---|
| Expenses | 316 | 329 | 360 | 363 | 386 | 403 | 444 | 480 |
| Operating profit | 115 | 131 | 128 | 136 | 144 | 161 | 170 | 176 |
| Operating margin | 26.7% | 28.5% | 26.2% | 27.3% | 27.2% | 28.6% | 27.8% | 26.8% |
| Other income | 12.7 | 15.4 | 13.4 | 7.9 | 10.5 | 12.6 | 6.4 | 9.8 |
| Interest | 28.4 | 25.0 | 24.7 | 22.6 | 21.1 | 22.1 | 23.4 | 23.0 |
| Depreciation | 58.2 | 60.4 | 63.0 | 67.9 | 68.8 | 76.7 | 78.3 | 82.7 |
| Profit before tax | 41.0 | 58.5 | 53.6 | 53.7 | 64.8 | 76.6 | 75.1 | 79.9 |
| Tax | 12.8 | 16.0 | 15.5 | 17.2 | 21.1 | 26.7 | 20.1 | 23.0 |
| Net profit | 22.3 | 32.6 | 30.1 | 29.7 | 33.7 | 39.7 | 45.2 | 54.7 |
| EPS (₹) | 0.73 | 1.04 | 0.95 | 0.94 | 1.07 | 1.25 | 1.43 | 1.65 |
₹ crore, financial years to March.
₹ crore, at each year's end and the latest half year.
₹ crore, by financial year, and the latest half year.
| Line | FY25 | FY26 | 6M to Sep 2026 |
|---|---|---|---|
| From operations | 360 | 519 | 280 |
| From investing | −750 | −308 | −234 |
| From financing | 382 | −220 | −36.9 |
| Spent on fixed assets | −309 | −448 | −257 |
| Free cash flow | 51.7 | 71.0 | 23.3 |
Margins, returns, debt, tax and cash.
| Line | FY25 | FY26 |
|---|---|---|
| Net margin | 4.9% | 6.4% |
| Operating margin | 26.7% | 27.4% |
| Return on equity | 4.5% | 6.6% |
| Return on capital employed | 12.7% | 15.5% |
| Return on assets | 2.3% | 3.4% |
| Debt to equity | 0.13 | 0.08 |
| Interest coverage | 2.50 | 3.70 |
| Debt to assets | 0.07 | 0.04 |
| Current ratio | 1.66 | 1.24 |
| Quick ratio | 1.49 | 1.04 |
| Cash ratio | 0.22 | 0.20 |
| Asset turnover | 0.47 | 0.53 |
| Fixed asset turnover | 2.42 | 2.25 |
| Inventory turnover | 2.00 | 2.10 |
| Receivables turnover | 13.80 | 12.90 |
| Gross margin | 90.5% | 90.7% |
| Cash from operations to profit | 432.0% | 390.0% |
| Effective tax rate | 31.0% | 32.4% |
Allotment of 54,728 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal's Health Care Limited - Employees Stock Option Scheme 2022
Appointment and Re-designation of Dr. Amar Agarwal, Chairman and Non-Executive Director of the Company, as the Executive Chairman (Whole-Time Director) of the Company
Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter and Half Year Ended September 30, 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Schedule of meet
Allotment of 18,200 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal's Health Care Limited - Employees Stock Option Scheme 2022
Record date for the purpose of Scheme of Amalgamation with Dr. Agarwal's Eye Hospital Limited is 18-Nov-2026.
Material Update on the Scheme of Amalgamation between Dr. Agarwal's Eye Hospital Limited and Dr. Agarwal's Health Care Limited and their respective shareholders and creditors
The receipt of Sanction from the Hon'ble NCLT, Chennai Bench towards the Scheme of Amalgamation between Dr. Agarwal s Eye Hospital Limited and Dr. Agarwal s Health Care Limited and their respective shareholders and creditors.
Update on step-down wholly owned subsidiary in Nigeria by Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.